Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
649.84
578.51
510.28
438.31
383.79
369.81
325.14
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
649.84
578.51
510.28
438.31
383.79
369.81
325.14
Raw Material Cost
404.89
371.29
340.59
293.06
266.34
265.28
238.54
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
126.14
132.15
117.06
99.97
94.66
95.90
89.93
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.59
1.44
1.15
1.41
1.79
2.76
4.86
Selling and Distribution Expenses
98.46
87.73
73.38
65.91
59.45
56.78
63.06
Other Expenses
-121.08
-126.00
-110.99
-94.16
-89.53
-91.05
-87.29
Total Expenditure (Excl Depreciation)
510.00
466.61
421.19
366.19
332.71
329.67
309.10
Operating Profit (PBDIT) excl Other Income
139.84
111.90
89.09
72.12
51.08
40.14
16.04
Other Income
8.48
4.57
3.92
4.06
5.64
5.97
5.45
Operating Profit (PBDIT)
168.55
131.63
106.89
90.24
71.84
60.87
35.23
Interest
1.59
1.44
1.15
1.41
1.79
2.76
4.86
Exceptional Items
87.35
4.72
1.44
0.00
0.00
-5.30
0.00
Gross Profit (PBDT)
244.95
207.22
169.69
145.25
117.45
104.53
86.60
Depreciation
21.43
17.07
15.50
15.66
16.47
16.36
15.32
Profit Before Tax
232.88
117.84
91.68
73.17
53.58
36.45
15.05
Tax
49.64
30.18
24.04
21.69
13.58
7.44
4.24
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
183.24
87.66
67.64
51.48
40.00
29.01
10.81
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
183.24
87.66
67.64
51.48
40.00
29.01
10.81
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
183.24
87.66
67.64
51.48
40.00
29.01
10.81
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
8.0
8.0
8.0
8.0
8.0
8.0
8.0
Reserves
530.53
374.85
307.60
255.77
216.45
176.57
160.50
Earnings per share (EPS)
110.79
53.0
40.9
31.13
24.19
17.54
6.54
Diluted Earnings per share
110.79
53.0
40.9
31.13
24.19
17.54
6.54
Operating Profit Margin (Excl OI)
21.33%
19.01%
17.14%
16.09%
12.96%
10.42%
4.45%
Gross Profit Margin
39.13%
23.32%
21.0%
20.27%
18.25%
14.28%
9.34%
PAT Margin
28.2%
15.15%
13.26%
11.75%
10.42%
7.84%
3.32%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 12.33% vs 13.37% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 109.03% vs 29.60% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 25.98% vs 23.40% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 10.42% vs 25.22% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of RPG LifeScience. With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
649.84
0
649.84
Other Operating Income
0.00
0.00
0.00
Total Operating income
649.84
0
649.84
Raw Material Cost
404.89
0
404.89
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
126.14
0
126.14
Power Cost
0
0
0.00
Manufacturing Expenses
1.59
0
1.59
Selling and Distribution Expenses
98.46
0
98.46
Other Expenses
-121.08
0.00
-121.08
Total Expenditure (Excl Depreciation)
510.00
0
510.00
Operating Profit (PBDIT) excl Other Income
139.84
0.00
139.84
Other Income
8.48
0
8.48
Operating Profit (PBDIT)
168.55
0
168.55
Interest
1.59
0
1.59
Exceptional Items
87.35
0
87.35
Gross Profit (PBDT)
244.95
0
244.95
Depreciation
21.43
0
21.43
Profit Before Tax
232.88
0
232.88
Tax
49.64
0
49.64
Provisions and contingencies
0
0
0.00
Profit After Tax
183.24
0
183.24
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
183.24
0
183.24
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
183.24
0
183.24
Equity Capital
0
0
0.00
Face Value
8.00
0
0.00
Reserves
530.53
0
530.53
Earnings per share (EPS)
110.79
0
110.79
Diluted Earnings per share
110.79
0
110.79
Operating Profit Margin (Excl OI)
21.33%
0%
0.00
21.33%
Gross Profit Margin
39.13%
0%
0.00
39.13%
PAT Margin
28.20%
0%
0.00
28.20%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 649.84 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 12.33% vs 13.37% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 183.24 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 109.03% vs 29.60% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 160.07 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 25.98% vs 23.40% in Mar 2024
Annual - Interest
Interest 1.59 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 10.42% vs 25.22% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.33%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
